RegenMD - Tissue Engineering and the International Space Station

RegenMD         Tissue Engineering and the International Space Station February 16, 2011 at 9:39 PM   (Image courtesy of Dr. David Wolf) This week, comments from guest blogger, medical doctor, engineer, and astronaut, Dr. David Wolf, as he reflects on tissue engineering in space. The International Space Station National Laboratory has an edge for doing ... See all stories on this topic » Space Ref (press release)         Tengion says rising stock price quashed merger talks February 16, 2011 at 10:00 AM   The recent climb in Tengion Inc.'s stock price has apparently derailed a potential sale of the East Norriton, Pa., regenerative medicine company. Tengion officials said Wednesday the company has been engaged in negotiations with a publicly traded ... See all stories on this topic »         More on Positive Feedback Loops at CIRM or "Them That Has Gets" February 16, 2011 at 9:42 AM         Study Confirms Third Trimester Amniotic Fluid a Reliable Source of Stem Cells ... February 16, 2011 at 8:37 AM   ... the leader in amniotic fluid banking, together with a group of collaborators, confirmed that amniotic fluid collected during the third trimester of pregnancy is a reliable source of stem cells for regenerative medicine and stem cell banking. ... See all stories on this topic »         Clinical trail for safe, affordable stem cell based medicine February 16, 2011 at 8:37 AM   The medicine specializing in these treatments is called cell-based therapies or regenerative medicine. Since this is the first-of-its-kind in India, the trail proposal went to Indian Council for Medical Research for review and recommendation. ... See all stories on this topic » TheMedGuru         Enduring questions about state's stem cell institute February 16, 2011 at 5:22 AM   As a concerned citizen, I explained my misgivings about the power an unregulated nongovernmental body, the California Institute for Regenerative Medicine (CIRM), would exercise over research grants provided by public funds. ... See all stories on this topic »         BioTime signs agreement to acquire Utah-based Glycosan BioSystems February 16, 2011 at 3:33 AM   Glycosan's products have the demonstrated ability to support the growth and directed differentiation of stem cells and are designed as implantable, resorbable matrices for tissue engineering, regenerative medicine, and for research applications ... See all stories on this topic »         From Salary to Leadership: Results on CIRM Survey on Criteria for New Chair February 16, 2011 at 2:43 AM         BioTime signs agreement to acquire Utah-based Glycosan BioSystems February 16, 2011 at 2:40 AM   BioTime, Inc., a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, announced it has signed a definitive agreement to merge Utah-based Glycosan BioSystems, Inc. (Glycosan) with BioTime's ... See all stories on this topic »         Exploring medicine through dance February 16, 2011 at 1:05 AM   The company will debut its ode to regenerative medicine and the scientists behind it Friday and Saturday at the Byham Theater, Downtown. The ballet is not the first time Ms. Caruso's work has grappled with medical themes. In 2010, Bodiography premiered ... See all stories on this topic » Pittsburgh Post Gazette         Arrowhead Reports 1Q Fiscal 2011 Financial Results February 16, 2011 at 1:05 AM   Arrowhead Research Corp. , a nanomedicine company with development programs in oncology, obesity, and regenerative medicine, announced financial results for its fiscal 2011 first quarter ended December 31, 2010. "With the sale of Unidym last month, ... See all stories on this topic »             This email was sent to agupta1213+termsc@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here